Human VSIR/VISTA HEK293T Stable Cell Line

Introduction

The Human VSIR/VISTA HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and potential therapeutic applications of the VSIR/VISTA protein. This cell line is derived from the human embryonic kidney 293T cell line and stably expresses the VSIR/VISTA protein, allowing for reliable and consistent results in experiments.

Structure of VSIR/VISTA Protein

The VSIR/VISTA protein is a type I transmembrane protein that is predominantly expressed on immune cells, including T cells, B cells, and myeloid cells. It is composed of an extracellular domain, a transmembrane domain, and a cytoplasmic tail. The extracellular domain contains an immunoglobulin (Ig)-like domain, which is important for protein-protein interactions, and a C-type lectin-like domain, which is involved in carbohydrate binding.

Activity of VSIR/VISTA Protein

The VSIR/VISTA protein has been shown to have both inhibitory and stimulatory effects on immune cells. It has been reported to inhibit T cell activation and proliferation, as well as cytokine production. On the other hand, it has also been shown to promote the differentiation of regulatory T cells and to enhance the function of myeloid-derived suppressor cells. These activities suggest that the VSIR/VISTA protein plays a crucial role in regulating immune responses and maintaining immune homeostasis.

Application of Human VSIR/VISTA HEK293T Stable Cell Line

The Human VSIR/VISTA HEK293T Stable Cell Line has a wide range of applications in the field of immunology and cancer research. Here are some specific examples:

1. Studying the role of VSIR/VISTA in immune cell function

Using the Human VSIR/VISTA HEK293T Stable Cell Line, researchers can investigate the effects of VSIR/VISTA on different immune cell populations. This can be done through co-culture experiments with T cells, B cells, or myeloid cells, and measuring changes in cell activation, proliferation, and cytokine production. Flow cytometry can also be used to analyze the expression of specific markers on these cells, providing valuable insights into the role of VSIR/VISTA in regulating immune responses.

2. Identifying potential therapeutic targets

The VSIR/VISTA protein has been identified as a potential therapeutic target for various diseases, including cancer and autoimmune disorders. The Human VSIR/VISTA HEK293T Stable Cell Line can be used to screen for potential drugs or antibodies that can modulate the activity of VSIR/VISTA. This can be achieved through high-throughput screenings and functional assays, providing a valuable platform for drug discovery and development.

3. Investigating the mechanism of action of VSIR/VISTA

The Human VSIR/VISTA HEK293T Stable Cell Line can also be used to study the intracellular signaling pathways that are activated or inhibited by VSIR/VISTA. By using various inhibitors or activators, researchers can dissect the molecular mechanisms behind the activity of VSIR/VISTA and its effects on immune cells. This knowledge can help in the development of more targeted and effective therapies for diseases involving dysregulated immune responses.

4. Developing immunotherapies targeting VSIR/VISTA

Immunotherapies, such as immune checkpoint inhibitors, have revolutionized the treatment of cancer. The Human VSIR/VISTA HEK293T Stable Cell Line can be used to test the efficacy of novel immunotherapies targeting VSIR/VISTA. By studying the effects of these therapies on the VSIR/VISTA protein, researchers can identify potential candidates for clinical trials and improve the success rate of these therapies.